• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利对一种被忽视疾病的忽视:贝加莫地区恰加斯病的医疗服务可及性挑战。

Neglect of a Neglected Disease in Italy: The Challenge of Access-to-Care for Chagas Disease in Bergamo Area.

作者信息

Repetto Ernestina Carla, Zachariah Rony, Kumar Ajay, Angheben Andrea, Gobbi Federico, Anselmi Mariella, Al Rousan Ahmad, Torrico Carlota, Ruiz Rosa, Ledezma Gabriel, Buoninsegna Maria Chiara, Khogali Mohammed, Van den Bergh Rafael, De Maio Gianfranco, Egidi Ada Maristella, Maccagno Barbara, Garelli Silvia

机构信息

Médecins Sans Frontières, Operational Centre Brussels, MSF-Belgium, Brussels, Belgium.

Médecins Sans Frontières, Medical Department, Operational Centre Brussels, MSF-Luxembourg, Luxembourg, Luxembourg.

出版信息

PLoS Negl Trop Dis. 2015 Sep 25;9(9):e0004103. doi: 10.1371/journal.pntd.0004103. eCollection 2015 Sep.

DOI:10.1371/journal.pntd.0004103
PMID:26406325
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4583374/
Abstract

OBJECTIVES

Chagas disease (CD) represents a growing problem in Europe; Italy is one of the most affected countries but there is no national framework for CD and access-to-care is challenging. In 2012 Médecins Sans Frontières (MSF) started an intervention in Bergamo province, where many people of Latin American origin (PLAO) are resident. A new model-of-care for CD, initiated by Centre for Tropical Diseases of Sacro Cuore Hospital, Negrar (CTD), the NGO OIKOS and the Bolivian community since 2009 in the same area, was endorsed. Hereby, we aim to describe the prevalence of CD and the treatment management outcomes among PLAO screened from 1st June 2012 to 30th June 2013.

METHODS

Retrospective cohort study using routine program data. Screening sessions were done in Bergamo at OIKOS outpatient service and serological confirmation, staging and treatment for CD was offered at the CTD. MSF provided health education on CD, awareness generation prior to screening days, pre-test and post-test counselling through cultural mediators of Latin American origin.

RESULTS

Of 1305 PLAO screened, 223(17%) had CD. Among 210 patients eligible for treatment, 102(49%) were lost-to-follow-up before treatment. The median delay from diagnosis to treatment was 4 months (range 0.7-16.6 months). Among 108 started on treatment, 63(58%) completed treatment, 36(33%) interrupted treatment, (33 for drug side-effects, two for patients decision and one due to pregnancy), 6(6%) were lost-to-follow-up and 3(3%) were on treatment at study censuring.

CONCLUSION

In this first study focusing on process of care for CD in Italy, less than 30% of patients completed treatment with drop-outs along the cascade of care. There is an urgent need to involve affected communities and local regional health authorities to take part to this model-of-care, adapting it to the local epidemiology. The Italian health authorities should take steps in advocating for a change in the current paradigm.

摘要

目的

恰加斯病(CD)在欧洲已成为一个日益严重的问题;意大利是受影响最严重的国家之一,但该国没有针对恰加斯病的国家框架,获得医疗服务具有挑战性。2012年,无国界医生组织(MSF)在贝加莫省启动了一项干预措施,该省有许多拉丁裔居民(PLAO)。自2009年以来,由内格拉尔圣心医院热带病中心(CTD)、非政府组织奥ikos和玻利维亚社区发起的一种新的恰加斯病护理模式在同一地区得到认可。在此,我们旨在描述2012年6月1日至2013年6月30日期间接受筛查的拉丁裔居民中恰加斯病的患病率和治疗管理结果。

方法

使用常规项目数据进行回顾性队列研究。在贝加莫的奥ikos门诊服务中心进行筛查,并在CTD进行恰加斯病的血清学确认、分期和治疗。无国界医生组织通过拉丁裔文化调解人提供关于恰加斯病的健康教育,在筛查日前提高认识,进行检测前和检测后咨询。

结果

在1305名接受筛查的拉丁裔居民中,223人(17%)患有恰加斯病。在210名符合治疗条件的患者中,102人(49%)在治疗前失访。从诊断到治疗的中位延迟时间为4个月(范围0.7 - 16.6个月)。在108名开始治疗的患者中,63人(58%)完成治疗,36人(33%)中断治疗(33人因药物副作用,2人因患者决定,1人因怀孕),6人(6%)失访,3人(3%)在研究审查时仍在接受治疗。

结论

在这项意大利首次关注恰加斯病护理过程的研究中,不到30%的患者完成治疗,在整个护理过程中存在患者退出的情况。迫切需要让受影响社区和地方区域卫生当局参与这种护理模式,并使其适应当地流行病学情况。意大利卫生当局应采取措施倡导改变当前模式。

相似文献

1
Neglect of a Neglected Disease in Italy: The Challenge of Access-to-Care for Chagas Disease in Bergamo Area.意大利对一种被忽视疾病的忽视:贝加莫地区恰加斯病的医疗服务可及性挑战。
PLoS Negl Trop Dis. 2015 Sep 25;9(9):e0004103. doi: 10.1371/journal.pntd.0004103. eCollection 2015 Sep.
2
Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Médecins Sans Frontières.洪都拉斯、危地马拉和玻利维亚恰加斯病病因学治疗方案的可行性、药物安全性和有效性:无国界医生组织 10 年经验。
PLoS Negl Trop Dis. 2009 Jul 7;3(7):e488. doi: 10.1371/journal.pntd.0000488.
3
Chagas disease in Italy: breaking an epidemiological silence.意大利的恰加斯病:打破流行病学的沉默。
Euro Surveill. 2011 Sep 15;16(37):19969.
4
[What is not searched, it is difficult to find: Chagas' disease].不探寻,便难以发现:恰加斯病
G Ital Cardiol (Rome). 2016 May;17(5):343-7. doi: 10.1714/2252.24258.
5
Anthropological study on Chagas Disease: Sociocultural construction of illness and embodiment of health barriers in Bolivian migrants in Rome, Italy.《关于恰加斯病的人类学研究:意大利罗马的玻利维亚移民中的疾病的社会文化构建和健康障碍的体现》。
PLoS One. 2020 Oct 16;15(10):e0240831. doi: 10.1371/journal.pone.0240831. eCollection 2020.
6
Chagas disease in Italy: the study's contribution of Italian researchers.意大利的查加斯病:意大利研究人员的研究贡献。
Panminerva Med. 2019 Dec;61(4):464-472. doi: 10.23736/S0031-0808.19.03723-6. Epub 2019 Jul 30.
7
Chagas disease: review of needs, neglect, and obstacles to treatment access in Latin America.恰加斯病:拉丁美洲治疗需求、忽视及治疗可及性障碍综述
Rev Soc Bras Med Trop. 2017 May-Jun;50(3):296-300. doi: 10.1590/0037-8682-0433-2016.
8
Congenital Chagas disease in a non-endemic area: Results from a control programme in Bergamo province, Northern Italy.先天性恰加斯病在非流行地区:意大利北部贝加莫省控制规划的结果。
Travel Med Infect Dis. 2018 Sep-Oct;25:31-34. doi: 10.1016/j.tmaid.2018.04.011. Epub 2018 Apr 20.
9
Chagas disease knocks on our door: a cross-sectional study among Latin American immigrants in Milan, Italy.恰加斯病敲响我们的大门:意大利米兰的拉丁美洲移民中的横断面研究。
Clin Microbiol Infect. 2018 Dec;24(12):1340.e1-1340.e6. doi: 10.1016/j.cmi.2018.03.017. Epub 2018 Mar 16.
10
Profile of Trypanosoma cruzi infection in a tropical medicine reference center, Northern Italy.意大利北部一家热带医学参考中心的克氏锥虫感染情况
PLoS Negl Trop Dis. 2014 Dec 11;8(12):e3361. doi: 10.1371/journal.pntd.0003361. eCollection 2014 Dec.

引用本文的文献

1
Heart failure patients' experiences of self-care neglect: a content analysis.心力衰竭患者自我护理疏忽的经历:一项内容分析。
BMC Cardiovasc Disord. 2024 Dec 20;24(1):736. doi: 10.1186/s12872-024-04347-3.
2
Prevalence of Chagas disease among Latin American immigrants in non-endemic countries: an updated systematic review and meta-analysis.非流行国家中拉丁美洲移民的恰加斯病患病率:一项最新的系统评价和荟萃分析。
Lancet Reg Health Eur. 2024 Sep 6;46:101040. doi: 10.1016/j.lanepe.2024.101040. eCollection 2024 Nov.
3
Community-based actions in consulates: a new paradigm for opportunities for systematic integration in Chagas disease detection.

本文引用的文献

1
Trypanocide treatment of women infected with Trypanosoma cruzi and its effect on preventing congenital Chagas.对感染克氏锥虫的女性进行杀锥虫治疗及其对预防先天性恰加斯病的作用。
PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3312. doi: 10.1371/journal.pntd.0003312. eCollection 2014 Nov.
2
Randomized trial of posaconazole and benznidazole for chronic Chagas' disease.随机试验泊沙康唑和苯硝唑治疗慢性恰加斯病。
N Engl J Med. 2014 May 15;370(20):1899-908. doi: 10.1056/NEJMoa1313122.
3
Impact of chagas disease in bolivian immigrants living in europe and the risk of stigmatization.
基于社区的领馆行动:在恰加斯病检测中系统整合机会的新模式。
BMC Infect Dis. 2023 Dec 1;23(1):847. doi: 10.1186/s12879-023-08844-2.
4
Chagas disease in Italy: an update of epidemiological studies.意大利的恰加斯病:流行病学研究的最新情况。
Infez Med. 2023 Sep 1;31(3):421-424. doi: 10.53854/liim-3103-18. eCollection 2023.
5
Diagnostic pathways of Chagas disease in Spain: a qualitative study.西班牙恰加斯病的诊断途径:一项定性研究。
BMC Public Health. 2023 Feb 14;23(1):332. doi: 10.1186/s12889-022-14938-4.
6
A Questionnaire Integrated with the Digital Medical Record Improved the Coverage of a Control Program for Congenital Chagas Disease in Tuscany, Italy.一份与数字病历相结合的问卷提高了意大利托斯卡纳先天性恰加斯病控制项目的覆盖率。
Microorganisms. 2023 Jan 6;11(1):154. doi: 10.3390/microorganisms11010154.
7
How people affected by Chagas disease have struggled with their negligence: history, associative movement and World Chagas Disease Day.受克氏锥虫病影响的人们如何与他们的疏忽作斗争:历史、联合运动和世界克氏锥虫病日。
Mem Inst Oswaldo Cruz. 2022 Jul 13;117:e220066. doi: 10.1590/0074-02760220066. eCollection 2022.
8
Population movements, borders, and Chagas disease.人口流动、边界和恰加斯病。
Mem Inst Oswaldo Cruz. 2022 Jul 8;117:e210151. doi: 10.1590/0074-02760210151. eCollection 2022.
9
COVID-19: an opportunity of systematic integration for Chagas disease. Example of a community-based approach within the Bolivian population in Barcelona.COVID-19:恰加斯病系统整合的机会。巴塞罗那玻利维亚人群中基于社区的方法示例。
BMC Infect Dis. 2022 Mar 28;22(1):298. doi: 10.1186/s12879-022-07305-6.
10
Worldwide Control and Management of Chagas Disease in a New Era of Globalization: a Close Look at Congenital Trypanosoma cruzi Infection.全球化新时代的查加斯病全球控制和管理:先天性克氏锥虫感染的深入观察。
Clin Microbiol Rev. 2022 Apr 20;35(2):e0015221. doi: 10.1128/cmr.00152-21. Epub 2022 Mar 3.
恰加斯病对生活在欧洲的玻利维亚移民的影响及污名化风险。
J Parasitol Res. 2014;2014:514794. doi: 10.1155/2014/514794. Epub 2014 Feb 27.
4
An unfolding tragedy of Chagas disease in North America.北美恰加斯病一场正在上演的悲剧。
PLoS Negl Trop Dis. 2013 Oct 31;7(10):e2300. doi: 10.1371/journal.pntd.0002300. eCollection 2013.
5
Improved completion rates and characterization of drug reactions with an intensive Chagas disease treatment program in rural Bolivia.强化治疗方案在玻利维亚农村地区提高了对恰加斯病药物不良反应的完成率和特征描述。
PLoS Negl Trop Dis. 2013 Sep 19;7(9):e2407. doi: 10.1371/journal.pntd.0002407. eCollection 2013.
6
Evaluating Chagas disease progression and cure through blood-derived biomarkers: a systematic review.通过血液生物标志物评估恰加斯病的进展和治愈:系统评价。
Expert Rev Anti Infect Ther. 2013 Sep;11(9):957-76. doi: 10.1586/14787210.2013.824718.
7
Epidemiology of Chagas disease in Europe: many calculations, little knowledge.欧洲恰加斯病的流行病学:大量计算,知之甚少。
Clin Res Cardiol. 2014 Jan;103(1):1-10. doi: 10.1007/s00392-013-0613-y. Epub 2013 Aug 29.
8
Benznidazole-related adverse drug reactions and their relationship to serum drug concentrations in patients with chronic chagas disease.苯唑哒唑相关药物不良反应及其与慢性恰加斯病患者血清药物浓度的关系。
Antimicrob Agents Chemother. 2013 Jan;57(1):390-5. doi: 10.1128/AAC.01401-12. Epub 2012 Oct 31.
9
American trypanosomiasis (Chagas disease).美洲锥虫病(恰加斯病)。
Infect Dis Clin North Am. 2012 Jun;26(2):275-91. doi: 10.1016/j.idc.2012.03.002.
10
Safety of benznidazole use in the treatment of chronic Chagas' disease.苯唑达唑治疗慢性恰加斯病的安全性。
J Antimicrob Chemother. 2012 May;67(5):1261-6. doi: 10.1093/jac/dks027. Epub 2012 Feb 13.